Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 12 Mar 2025 for Trevi Therapeutics, Inc., €477k.
Filing timeline
BuySaleFarrell Simon
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Farrell Simon: trading record in brief
Farrell Simon discloses dealings in Trevi Therapeutics, Inc. to SEC (Form 4). We count 7 filings; the first trade dates from 7 March 2023 and the latest from 10 March 2025.
The open-market record consists of 2 sales worth €505k, with no purchase. Other entries cover 5 option exercises. So far in 2025, the count stands at no purchases and 2 sales.
Most recently, on 12 March 2025, the filings show an open-market sale worth €477k in Trevi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Farrell Simon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
76,963 shares@ US$6.727658.6% of flowCommon StockSEC:0000950170-25-037880:3
63,813 shares@ US$3.9128.2% of flowCommon StockSEC:0000950170-25-037880:1
31,250 shares@ US$0.5111.8% of flowCommon StockSEC:0000950170-25-037880:2
4,350 shares@ US$7.14983.5% of flowCommon StockSEC:0000950170-25-037880:4
17,500 shares@ US$3.2181.3% of flowCommon StockSEC:0000950170-25-037880:0
6,250 shares@ US$0.5114.6% of flowCommon StockSEC:0001209191-23-038744:0
18,750 shares@ US$0.51114.1% of flowCommon StockSEC:0001209191-23-017148:0
7 of 7 declarations
